If you’ve been following along, you’ll know that September was a big month for BIOLIFE4D. We re-opened our Regulation A+ equity crowdfunding campaign and then, thanks to the tremendous advancements that were made in our lab – which we’ll get to – we announced that we increased the price per share to $13.50, which represents a 35% increase in share price since our original offering!
Of course, we’re excited about the investment progress we’ve made, but the highlight of the month was announcing that we’ve successfully 3D bioprinted a mini-heart. This is a significant milestone on our way towards our ultimate goal of bioprinting a full-sized human heart viable for transplant, and it generated media coverage from all over the globe! In case you missed any, please find some of our favorites below:
Chicago biotech company uses its proprietary bioink, bioprinting algorithm, and cardiomyocytes to create an organ that replicates functions of the human heart.
BIOLIFE4D first bioprinted human cardiac tissue in June 2018. Earlier this year, the company bioprinted individual heart components, including valves, ventricles and blood vessels. Its process involves reprogramming a patient’s white blood cells into induced pluripotent stem cells (iPS cells), which can differentiate into different types of cells, including cardiac cells.
Digital Trends – Biotech company 3D-prints a miniature human heart from stem cells
Digital Trends spoke with Biolife4D Chief Science Officer, Ravi Birla, about this remarkable achievement and what the future of organ printing holds. The 3D-printed mini heart, which you can see below, has the same structure as a real heart with its four internal chambers. The aim was to create something similar enough to a real heart that it can be used for cardiotoxicity testing — that is, for drug companies and medical researchers to test what happens to a heart when it suffers problems with the muscle or with heart beats.
There’s a national shortage of donor organs in the United States — a terrifying predicament for the hundreds of thousands of patients on transplant waiting lists. But a new technology has the chance to one day make the donor organ obsolete. Chicago-based biotech outfit Biolife4D claims to have 3D bioprinted a miniaturized human heart — chambers, ventricles, and all. Though it’s still years out, the long-term goal is to print a full-scale human hearts that can be transplanted into human patients, like changing out a watch battery.
ABC 7 – Bioengineered 3-D printed mini heart could change lives of heart disease patients
3-D printing could change the lives of heart patients after a company based in Chicago announced they’ve created a mini-heart made with a 3D printer. “We are recreating the circumstances outside the body that mother nature took millions of years to perfect inside the body,” said BIOLIFE4D CEO Steve Morris.
If this is as exciting to you as it is to us, share your excitement with your friends and family. Share our story throughout your social network. Share the incredible press we have received. Let everyone know about who we are and what our mission is. Together we can change the world. Together we can save lives. Let everyone know what you are a part of.
To learn more about our mission and our incredible technology or if you have interest in investing please click here.
— Team at BIOLIFE4D
Got heart? Support BIOLIFE4D as we work to better humanity’s future. Invest now to build a heart and save a life.